Among the various T-ALL oncogenic alterations reported to date, gain-of-function alterations in transcriptional factors such as LYL1, HOXA, TAL1, TLX1, and TLX3 represent a recurrent oncogenic hallmark of T-ALL [27]. This evidence concerns the gene TLX1 and acute lymphoblastic leukemia.